Welcome to LookChem.com Sign In|Join Free
  • or
4H-Pyrazol-4-one, 3,5-diamino-, [3-fluoro-4-(4-morpholinylmethyl)phenyl]hydrazone is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

503183-33-3

Post Buying Request

503183-33-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

503183-33-3 Usage

Chemical compound

4H-Pyrazol-4-one, 3,5-diamino-, [3-fluoro-4-(4-morpholinylmethyl)phenyl]hydrazone

Derived from a pyrazolone

It is a hydrazone derived from a pyrazolone

Structure

Contains a pyrazolone ring with a diamino group at the 3 and 5 positions, as well as a fluoro-substituted phenyl ring with a morpholinylmethyl group

Pharmaceutical research

Used in pharmaceutical research as a potential drug candidate

Biological activities

Has potential biological activities and may be used in the development of new pharmaceuticals for various applications, including cancer treatment and antimicrobial therapy.

Check Digit Verification of cas no

The CAS Registry Mumber 503183-33-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,3,1,8 and 3 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 503183-33:
(8*5)+(7*0)+(6*3)+(5*1)+(4*8)+(3*3)+(2*3)+(1*3)=113
113 % 10 = 3
So 503183-33-3 is a valid CAS Registry Number.

503183-33-3Downstream Products

503183-33-3Relevant academic research and scientific papers

Pyrazole compounds

-

, (2008/06/13)

Pharmaceutical compositions and compounds are provided. The compounds of the invention demonstrate anti-proliferative activity, and may promote apoptosis in cells lacking normal regulation of cell cycle and death. In one embodiment of the invention, pharmaceutical compositions of the compounds in combination with a physiologically acceptable carrier are provided. The pharmaceutical compositions are useful in the treatment of hyperproliferative disorders, which disorders include tumor growth, lymphoproliferative diseases, angiogenesis. The compounds of the invention are substituted pyrazoles and pyrazolines.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 503183-33-3